COVID-19 rapid test

for antigensSARS-COV-2influenza A

Non-invasive diagnosis. Nasopharyngeal swab sample. No need for additional equipment. Ail components included in the kit. Low cost throughout the process. Very simple use and interpretation. More amount of analysis in the same time. Workflflow SARS-CoV-2. Recent studies have shown that the primary viral infection found in symptomatic patients was identi-cal to that seen in asymptomatic patients, suggesting that COVID-19 patients with asymptomatic infections are capable of transmitting SARS-CoV-2. Influenza A. Influenza epidemies are repeated annually and can affect people of ail âges, although there is a high risk of complications in children under two years of âge and adults over 65 years of âge. This risk also exists in people of any âge with certain health problems, such as chronic heart, lung, kidney, liver, blood or metabolic diseases (for example, diabetes), or immunocompromised people. Influenza B. The flu causes between 3 and 5 million serious cases annually. Three-quarters of individuals develop acute respiratory illness and one-third require médical attention. Annually, there are between 300,000 and 650,000 deaths related to this disease.